TABLE 1.
Demographic and clinical characteristics of 57 patients with anorexia nervosa and 57 gender‐, age‐ and body mass index‐matched controls treated during and before the COVID‐19 pandemic, respectively
| Patients exposed to pandemic (n = 57) | Controls (n = 57) | t‐test, Mann–Whitney test or chi‐squared test | p value | |
|---|---|---|---|---|
| Gender, % females | 53 (93.0%) | 53 (93.0%) | — | — |
| Age, years | 26.4 (10.3) | 25.6 (10.1) | Z = 0.64 | .525 |
| Body Mass Index, kg/m2 | 15.0 (2.1) | 14.8 (2.0) | t = 0.69 | .492 |
| EDE‐Q global score | 4.0 (1.2) | 4.1 (1.3) | Z = 0.69 | .488 |
| EDE‐Q objective binge‐eating episodes, mean (SD), if present | 16.9 (16.7) | 15.7 (22.6) | Z = 0.83 | .407 |
| EDE‐Q self‐induced vomiting, mean (SD), if present | 19.2 (18.7) | 27.6 (33.3) | Z = 0.30 | .761 |
| EDE‐Q laxative misuse, mean (SD), if present | 4.9 (4.5) | 15.6 (18.5) | Z = 1.36 | .174 |
| EDE‐Q excessive exercise, mean (SD), if present | 21.2 (21.4) | 20.1 (10.4) | Z = 0.98 | .327 |
| CIA global score | 34.6 (11.8) | 37.8 (8.5) | Z = 1.09 | .277 |
| BSI global score | 1.89 (0.8) | 2.25 (0.7) | t = 2.44 | .016 |
Note: Data are presented as mean (SD) or as number (%).
Abbreviations: BSI, brief symptom inventory; EDE‐Q, Eating Disorder Examination Questionnaire; CIA, clinical impairment assessment.